Oxytocin prolongs the gastric emptying time in patients with diabetes mellitus and gastroparesis, but does not affect satiety or volume intake in patients with functional dyspepsia

BMC Research Notes

Bodil Ohlsson¹  Julia Borg¹ 

[1] Department of Clinical Sciences, Division of Gastroenterology, Skåne University Hospital, Malmö, Lund University, Lund, Sweden

关键词: Slow satiety drinking test;    Gastric emptying scintigraphy;    Gastroparesis;    Functional dyspepsia;    Diabetes mellitus;   

Others  :  1166580
DOI  :  10.1186/1756-0500-5-148

 received in 2011-12-01, accepted in 2012-03-16,  发布年份 2012

【 摘 要 】

Background

Oxytocin is released in response to a fatty meal. Blockage of the oxytocin receptor led to slower gastric emptying whereas stimulation resulted in less satiety in healthy volunteers. Patients with diabetes mellitus and gastroparesis lack oxytocin elevation, and dyspepsia is partly caused by reduced fundus accommodation causing early satiety and related symptoms. The aim of this study was thus to examine the effect of oxytocin on gastric emptying, satiety and volume intake in patients with gastrointestinal pathology.

Results

Gastric emptying scintigraphy was performed twice in 12 patients with diabetic gastroparesis, once with oxytocin and once with saline as intravenous infusions. The patients scored their sensation of satiety using a visual analogue scale (VAS). The gastric emptying in patients with gastroparesis was prolonged during oxytocin infusion (p = 0.034) without affecting satiety. A slow satiety drinking test was performed in 14 patients with functional dyspepsia. The patients scored their satiety every five minutes until maximal satiety was reached, and the total volume was determined. The VAS was also completed 30 minutes afterwards. The test was performed twice, once with oxytocin and once with saline as intravenous infusions. There was no difference in satiety scores or volume of nutrient intake between saline and oxytocin infusions, either before, during or after the meal.

Conclusions

Oxytocin prolongs gastric emptying in patients with diabetes mellitus and gastroparesis, but has no effect on volume of nutrient intake or satiety and other related symptoms in patients with functional dyspepsia.

【 授权许可】

   
2012 Ohlsson et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Monstein HJ, Grahn N, Truedsson M, Ohlsson B: Oxytocin and oxytocin-receptor mRNA expression in the human gastrointestinal tract: a polymerase chain reaction study. Regul Pept 2004, 119:39-44.
• [2]Ohlsson B, Truedsson M, Djerf P, Sundler F: Oxytocin is expressed throughout the human gastrointestinal tract. Regul Pept 2006, 135:7-11.
• [3]Ohlsson B, Forsling ML, Rehfeld JF, Sjolund K: Cholecystokinin stimulation leads to increased oxytocin secretion in women. Eur J Surg 2002, 168:114-118.
• [4]Borg J, Melander O, Johansson L, Uvnas-Moberg K, Rehfeld JF, Ohlsson B: Gastroparesis is associated with oxytocin deficiency, oesophageal dysmotility with hyperCCKemia, and autonomic neuropathy with hypergastrinemia. BMC Gastroenterol 2009, 9:17. BioMed Central Full Text
• [5]Ohlsson B, Bjorgell O, Ekberg O, Darwiche G: The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human. BMC Gastroenterol 2006, 6:11. BioMed Central Full Text
• [6]Hashmonai M, Torem S, Argov S, Barzilai A, Schramek A: Prolonged post-vagotomy gastric atony treated by oxytocin. Br J Surg 1979, 66:550-551.
• [7]Petring OU: The effect of oxytocin on basal and pethidine-induced delayed gastric emptying. Br J Clin Pharmacol 1989, 28:329-332.
• [8]Borg J, Simren M, Ohlsson B: Oxytocin reduces satiety scores without affecting the volume of nutrient intake or gastric emptying rate in healthy subjects. Neurogastroenterol Motil 2011, 23:56-61.
• [9]McCann MJ, Verbalis JG, Stricker EM: LiCl and CCK inhibit gastric emptying and feeding and stimulate OT secretion in rats. Am J Physiol 1989, 256:R463-R468.
• [10]Verbalis JG, McCann MJ, McHale CM, Stricker EM: Oxytocin secretion in response to cholecystokinin and food: differentiation of nausea from satiety. Science 1986, 232:1417-1419.
• [11]Wu CL, Hung CR, Chang FY, Pau KY, Wang JL, Wang PS: Involvement of cholecystokinin receptor in the inhibition of gastric emptying by oxytocin in male rats. Pflugers Arch 2002, 445:187-193.
• [12]Wu CL, Hung CR, Chang FY, Pau KY, Wang PS: Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats. Naunyn Schmiedebergs Arch Pharmacol 2003, 367:406-413.
• [13]Qin J, Feng M, Wang C, Ye Y, Wang PS, Liu C: Oxytocin receptor expressed on the smooth muscle mediates the excitatory effect of oxytocin on gastric motility in rats. Neurogastroenterol Motil 2009, 21:430-438.
• [14]Tack J, Caenepeel P, Piessevaux H, Cuomo R, Janssens J: Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut 2003, 52:1271-1277.
• [15]Tack J: Prokinetics and fundic relaxants in upper functional GI disorders. Curr Opin Pharmacol 2008, 8:690-696.
• [16]Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association: American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004, 127:1592-1622.
• [17]Faraj J, Melander O, Sundkvist G, Olsson R, Thorsson O, Ekberg O, Ohlsson B: Oesophageal dysmotility, delayed gastric emptying and gastrointestinal symptoms in patients with diabetes mellitus. Diabet Med 2007, 24:1235-1239.
• [18]Kong MF, Horowitz M: Diabetic gastroparesis. Diabet Med 2005, 22(Suppl 4):13-18.
• [19]Parkman HP, Camilleri M, Farrugia G, McCallum RW, Bharucha AE, Mayer EA, Tack JF, Spiller R, Horowitz M, Vinik AI, Galligan JJ, Pasricha PJ, Kuo B, Szarka LA, Marciani L, Jones K, Parrish CR, Sandroni P, Abell T, Ordog T, Hasler W, Koch KL, Sanders K, Norton NJ, Hamilton F: Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil 2010, 22:113-133.
• [20]Shapiro RE, Miselis RR: The central organization of the vagus nerve innervating the stomach of the rat. J Comp Neurol 1985, 238:473-488.
• [21]Ueta Y, Kannan H, Yamashita H: Gastric afferents to the paraventricular nucleus in the rat. Exp Brain Res 1991, 84:487-494.
• [22]Ermisch A, Barth T, Ruhle HJ, Skopkova J, Hrbas P, Landgraf R: On the blood-brain barrier to peptides: accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions. Endocrinol Exp 1985, 19:29-37.
• [23]Flanagan LM, Olson BR, Sved AF, Verbalis JG, Stricker EM: Gastric motility in conscious rats given oxytocin and an oxytocin antagonist centrally. Brain Res 1992, 578:256-260.
• [24]Galligan JJ, Vanner S: Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol Motil 2005, 17:643-653.
• [25]Schwizer W, Borovicka J, Kunz P, Fraser R, Kreiss C, D'Amato M, Crelier G, Boesiger P, Fried M: Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Gut 1997, 41:500-504.
• [26]Feinle C, Meier O, Otto B, D'Amato M, Fried M: Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001, 48:347-355.
• [27]D'Amato W, Thompson DG, Spiller RC, Giacovelli G, Griffin PH, Schneier H, Lucio RC: The CCK1 receptor antagonist dexloxiglumide is effective and safe in female patients with constipation predominant irritable bowel syndrome. Am J Gastroenterol 2001, 96:S317.
• [28]Ohlsson B, Truedsson M, Bengtsson M, Torstenson R, Sjölund K, Björnsson ES, Simrèn M: Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. Neurogastroenterol Motil 2005, 17:697-704.
• [29]Petersson M, Alster P, Lundeberg T, Uvnas-Moberg K: Oxytocin increases nociceptive thresholds in a long-term perspective in female and male rats. Neurosci Lett 1996, 212:87-90.
• [30]Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V: Functional gastroduodenal disorders. Gastroenterology 2006, 130:1466-1479.
• [31]Talley NJ, Walker MM, Aro P, Ronkainen J, Storskrubb T, Hindley LA, Harmsen WS, Zinsmeister AR, Agréus L: Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol 2007, 5:1175-1183.
• [32]Friesen CA, Lin Z, Singh M, Singh V, Schurman JV, Burchell N, Cocjin JT, McCallum RW: Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia. Dig Dis Sci 2008, 53:2634-2640.
• [33]Karamanolis G, Caenepeel P, Arts J, Tack J: Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006, 130:296-303.
• [34]Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC: Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007, 19:62-88.
• [35]Camilleri M: Functional dyspepsia: mechanisms of symptom generation and appropriate management of patients. Gastroenterol Clin North Am 2007, 36:649-664.
• [36]Talley NJ, Choung RS: Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009. J Gastroenterol Hepatol 2009, 24(Suppl 3):20-28.
• [37]Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115:1346-1352.
• [38]Elsenbruch S, Rosenberger C, Enck P, Forsting M, Schedlowski M, Gizewski ER: Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut 2010, 59:489-495.
• [39]Beckers EJ, Rehrer NJ, Saris WH, Brouns F, Ten Hoor F, Kester AD: Daily variation in gastric emptying when using the double sampling technique. Med Sci Sports Exerc 1991, 23:1210-1212.
• [40]Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M: Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 2002, 19:177-194.
• [41]Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006, 130:1377-1390.
• [42]Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, Mosca A, Mauri P, Paroni R, Susanto F, Takei I, Thienpont L, Umemoto M, Wiedmeyer H-M, the IFCC working group on HbA1c standardization: IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004, 50:166-174.
• [43]Hanson M, Lilja B: Gastric emptying in smokers. Scand J Gastroenterol 1987, 22:1102-1104.